CHRS logo

Coherus BioSciences (CHRS) Non Current Assets

CHRS Annual Non Current Assets

$153.97 M
+$54.36 M+54.57%

31 December 2023

CHRS Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CHRS Quarterly Non Current Assets

$135.98 M
+$19.05 M+16.29%

30 September 2024

CHRS Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CHRS Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+54.6%-2.5%
3 y3 years+107.6%+61.7%
5 y5 years+924.2%+61.7%

CHRS Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+99.9%-11.7%+76.6%
5 y5-yearat high+133.6%-11.7%+106.3%
alltimeall timeat high+8779.6%-11.7%+7582.3%

Coherus BioSciences Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$135.98 M(+16.3%)
June 2024
-
$116.92 M(-14.1%)
Mar 2024
-
$136.07 M(-11.6%)
Dec 2023
$475.63 M(+24.8%)
$153.97 M(+10.4%)
Sept 2023
-
$139.42 M(+65.8%)
June 2023
-
$84.11 M(-2.8%)
Mar 2023
-
$86.50 M(-13.2%)
Dec 2022
$381.23 M(-36.7%)
$99.61 M(-2.9%)
Sept 2022
-
$102.63 M(+3.4%)
June 2022
-
$99.22 M(+22.6%)
Mar 2022
-
$80.94 M(+5.1%)
Dec 2021
$602.32 M(-21.5%)
$77.01 M(+12.1%)
Sept 2021
-
$68.69 M(-13.6%)
June 2021
-
$79.53 M(+4.6%)
Mar 2021
-
$76.04 M(+2.5%)
Dec 2020
$767.48 M(+123.7%)
$74.17 M(-3.4%)
Sept 2020
-
$76.81 M(-4.9%)
June 2020
-
$80.75 M(+13.2%)
Mar 2020
-
$71.36 M(+8.2%)
Dec 2019
$343.01 M
$65.92 M(+29.2%)
Sept 2019
-
$51.01 M(+46.5%)
June 2019
-
$34.83 M(+29.2%)
DateAnnualQuarterly
Mar 2019
-
$26.96 M(+79.3%)
Dec 2018
$84.43 M(-42.0%)
$15.03 M(+34.9%)
Sept 2018
-
$11.15 M(-28.2%)
June 2018
-
$15.53 M(-4.2%)
Mar 2018
-
$16.22 M(-5.3%)
Dec 2017
$145.48 M(-9.9%)
$17.13 M(-5.6%)
Sept 2017
-
$18.15 M(-4.0%)
June 2017
-
$18.91 M(-1.7%)
Mar 2017
-
$19.23 M(+13.2%)
Dec 2016
$161.49 M(-18.2%)
$17.00 M(+13.0%)
Sept 2016
-
$15.04 M(+5.4%)
June 2016
-
$14.27 M(-2.6%)
Mar 2016
-
$14.65 M(-2.3%)
Dec 2015
$197.39 M(+10.2%)
$15.00 M(+15.3%)
Sept 2015
-
$13.01 M(+30.7%)
June 2015
-
$9.95 M(+7.5%)
Mar 2015
-
$9.26 M(+14.5%)
Dec 2014
$179.14 M(+292.2%)
$8.09 M(-21.6%)
Sept 2014
-
$10.31 M(+37.9%)
June 2014
-
$7.47 M(+322.3%)
Dec 2013
$45.68 M(+84.2%)
$1.77 M
Dec 2012
$24.80 M
-

FAQ

  • What is Coherus BioSciences annual long term assets?
  • What is the all time high annual non current assets for Coherus BioSciences?
  • What is Coherus BioSciences annual non current assets year-on-year change?
  • What is Coherus BioSciences quarterly long term assets?
  • What is the all time high quarterly non current assets for Coherus BioSciences?
  • What is Coherus BioSciences quarterly non current assets year-on-year change?

What is Coherus BioSciences annual long term assets?

The current annual non current assets of CHRS is $153.97 M

What is the all time high annual non current assets for Coherus BioSciences?

Coherus BioSciences all-time high annual long term assets is $153.97 M

What is Coherus BioSciences annual non current assets year-on-year change?

Over the past year, CHRS annual long term assets has changed by +$54.36 M (+54.57%)

What is Coherus BioSciences quarterly long term assets?

The current quarterly non current assets of CHRS is $135.98 M

What is the all time high quarterly non current assets for Coherus BioSciences?

Coherus BioSciences all-time high quarterly long term assets is $153.97 M

What is Coherus BioSciences quarterly non current assets year-on-year change?

Over the past year, CHRS quarterly long term assets has changed by -$3.44 M (-2.47%)